📢We want to hear from you! 🔎UPD is undergoing an evaluation to better understand and evidence our impact, and improve how we support our stakeholders. 🌟No matter how you've engaged with us, we would appreciate your feedback. 🔗Take the survey here: surveymonkey.com/r/updevaluation

The Department of Health and Social Care has announced £400 million investment to boost clinical trials. Given the challenges in embedding research in the NHS, this funding is welcome. It has the potential to make the NHS more attractive for clinical research and trials, benefitting patients and the UK.

The life science industry has the potential to deliver so much more for the UK - but to do this we need to fix the NHS, improve patient access to medicines and invest more in our critical science and regulatory infrastructure. This world-first Investment Programme puts industry

This world-first VPAG Investment Programme puts industry money behind the government’s vision to make better health and science a driver of economic growth. thetimes.com/business-money…

.Health Innovation Network Chair Richard Stubbs FRSA knows how important innovation is to patients, and that effective partnerships can help create that innovation. Read our guidance to learn how the NHS and industry can partner effectively bit.ly/46BPaHt

Peru has become the sixth country to ratify the UK’s CPTPP membership. This means the UK has now reached enough signatures to enter the dynamic trade group as a full member by 15 December 2024. The countdown begins. Read more 👉 gov.uk/government/new…

💪 Strengthening its place as a home of cutting-edge research, the UK Government has announced that a landmark £400m investment will help expand the country’s life sciences sector and boost clinical trial participation, sustainable manufacturing, and horizon scanning

UK secures £400 million investment to boost clinical trials 🧵1/3 From our President Professor Andrew Morris PMedSci: "The Academy of Medical Sciences warmly welcomes this groundbreaking £400m investment programme." gov.uk/government/new… Department of Health and Social Care NHS England ABPI

Applications are now open for the new UK Research and Innovation CEO 🔬 This is a unique chance to influence how science and technology improve lives in the UK, enhance public services, and boost the economy. Apply here 👇 saxbam.com/appointment/uk… (1/2)

Our Vice President Russell Abberley of Amgen 🧪🔬🧬 wants to encourage partnerships, to make great things happen for patients. #powerofpartnerships We have guidance with NHS Confederation to help companies and the NHS make their partnerships a success bit.ly/46BPaHt

Today, our Vice-President Russell Abberley of Amgen 🧪🔬🧬 becomes Acting ABPI President. He will continue work to make the 🇬🇧the best place in the 🌍 to research, develop & use new medicines and vaccines. 🔬💊💉 More: bit.ly/3XuxhHH

Did you know: Industry clinical trials benefit the NHS and the economy. Find out how in our report on the value of industry clinical trials.🔬🖥️🧬 bit.ly/3Xwapr9

Our board member Şeyda Atadan-Memiş of @TakedaUKandIreland understands the #PowerofPartnerships between the NHS and industry to improve patient care. Our practical guide will help companies and the NHS work together effectively. bit.ly/46BPaHt

Excellent report from ABPI Dementia a good test case-there are over 160 trials globally for Alzheimer’s therapies. The UK needs to be a leading location for these trials both for the economic benefit but also to ensure UK patients can access promising new treatments.

Clinical trials are good for the NHS, particularly at a time when it is under so much pressure. Find out more in our report on the value of industry clinical trials. bit.ly/3Xwapr9

We'd also like to congratulate the organisations which were recertified in August. Well done ABPI, Bliss Baby Charity, Lyme Disease Action, The Migraine Trust, MSD and UKPIPS! Your recertification shows your continued commitment to trusted #HealthInformation.

Industry clinical trials support tens of thousands of jobs across the UK, in the NHS, pharmaceutical industry, and associated supply chains. Find out more: bit.ly/3Xwapr9

Yesterday, Patrick Vallance opened our new lab at The Crick in London! We are advancing discovery science with a growing London-based team committed to innovation. Excited to build on MSD’s 100-year heritage in the UK! msd-uk.com/stories/msd-un… Ben Lucas

Ioana Parsons leads Ipsen in the UK&I. She knows that the benefits to patients can be significant, with the #PowerofPartnerships. Our guidance with NHS Confederation on how to make NHS-industry partnerships successful: bit.ly/46BPaHt

.Wes Streeting MP talked about the need for greater collaboration between the NHS and life sciences, alongside wider shifts needed in the NHS in the Financial Times See successful partnerships in our library bit.ly/46NdGp3 ft.com/content/1e71c9… #PowerofPartnerships